Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01114711 · ClinicalTrials.gov registry record
Frovatriptan and Menstrual Migraine
A clinical trial, sponsored by Mclean Hospital.
- Terminated
- Registry status
- 24
- Enrollment target
NCT01114711 is a clinical trial that was terminated before completion, run by Mclean Hospital. The registered enrollment target is 24 participants.
The verdict
NCT01114711 was terminated before completion, sponsored by Mclean Hospital.
- TERMINATED
- Registry status
- 24 participants
- Enrollment target
Study Summary
We are looking for women who suffer from menstrual migraine to participate in a 2-visit migraine brain imaging research study. Our goal is to see how the menstrual migraine brain's pain pathways function when the migraineur has been taking Frovatriptan. During the screening visit (Visit 1) participants will sign the informed consent form, complete questionnaires, meet with the study physician, and have QST (quantitative sensory testing: to determine your pain thresholds for a heat stimulus) performed. For Visit 2's MRI scan, subjects will be asked to lie very still while the scan is occurring. In some parts, they will not have to do anything, while in others they will be asked to rate pain and unpleasantness for brush and thermal stimuli. Participants are compensated for both visits.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-04 |
| Est. Completion | 2010-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01114711
The ClinicalTrials.gov registry entry for NCT01114711 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01114711 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01114711 about?
NCT01114711 is a clinical study titled "Frovatriptan and Menstrual Migraine". We are looking for women who suffer from menstrual migraine to participate in a 2-visit migraine brain imaging research study. Our goal is to see how the menstrual migraine brain's pain pathways function when the migraineur has been taking Frovatriptan. During the screening visit (Visit 1) participa...
What is the current status of trial NCT01114711?
This trial is currently terminated. The enrollment target is 24 participants. The study started on 2010-04. Estimated completion is 2010-05.
Who is sponsoring clinical trial NCT01114711?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.